About Neutrophil cytosol factor 2
Neutrophil cytosol factor 2 (NCF2) is a protein
from Homo sapiens identified by UniProt accession
P19878, 526 residues long.
MolForge cross-references it against 0 known binders and
320 disease associations.
Target properties
| Protein name | Neutrophil cytosol factor 2 |
| UniProt accession | P19878 |
| Gene | NCF2 |
| Organism | Homo sapiens |
| Length | 526 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (320)
Diseases linked to this target (Open Targets).
- chronic granulomatous disease · score 0.67
- systemic lupus erythematosus · score 0.46
- neutrophil count · score 0.34
- total blood protein measurement · score 0.29
- breast adenocarcinoma · score 0.25
- rheumatoid arthritis · score 0.21
- celiac disease · score 0.21
- eosinophil count · score 0.21
- neutrophil percentage of leukocytes · score 0.21
- genetic disorder · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P19878-F1 | alphafold | PREDICTED | 78.54 | — |
Amino-acid sequence (526 residues)
MSLVEAISLW NEGVLAADKK DWKGALDAFS AVQDPHSRIC FNIGCMYTIL KNMTEAEKAF TRSINRDKHL AVAYFQRGML YYQTEKYDLA IKDLKEALIQ LRGNQLIDYK ILGLQFKLFA CEVLYNIAFM YAKKEEWKKA EEQLALATSM KSEPRHSKID KAMECVWKQK LYEPVVIPVG KLFRPNERQV AQLAKKDYLG KATVVASVVD QDSFSGFAPL QPQAAEPPPR PKTPEIFRAL EGEAHRVLFG FVPETKEELQ VMPGNIVFVL KKGNDNWATV MFNGQKGLVP CNYLEPVELR IHPQQQPQEE SSPQSDIPAP PSSKAPGRPQ LSPGQKQKEE PKEVKLSVPM PYTLKVHYKY TVVMKTQPGL PYSQVRDMVS KKLELRLEHT KLSYRPRDSN ELVPLSEDSM KDAWGQVKNY CLTLWCENTV GDQGFPDEPK ESEKADANNQ TTEPQLKKGS QVEALFSYEA TQPEDLEFQE GDIILVLSKV NEEWLEGECK GKVGIFPKVF VEDCATTDLE STRREV
Explore Neutrophil cytosol factor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets